SOX2 and hepatocellular carcinoma: Down-regulation of NANOG in human hepatocellular carcinoma decreases the expression of SOX2, OCT4, and KLF4, giving rise to the reduced proliferation, invasion, and migration of cancer cells[34 ▶].